Volume 28, Number 10—October 2022
Dispatch
Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections
Table
Parameter | Patient A | Patient B |
---|---|---|
Hematology | ||
Hemoglobin, g/dL | 9.8 | 9.2 |
Packed cell volume, % | 26.40 | 31.40 |
Erythrocytes, × 109 cells/L | 3.04 | 3.77 |
Mean corpuscular volume, fL | 88.5 | 83.3 |
Mean corpuscular hemoglobin, pg | 32.2 | 24.4 |
Mean corpuscular hemoglobin concentration, g/dL | 36.4 | 29.3 |
Red cell distribution width, % | 29.2 | 27.4 |
Platelets/mm3 | 155,000 | 140,000 |
Mean platelet volume, fL | 12.4 | 10.3 |
Platelet distribution width, % | 28.1 | 27.4 |
Total leukocytes, x 109 cells/L | 7,800 | 14,400 |
Neutrophils, % | 66.40 | NA |
Lymphocytes, % | 18.50 | NA |
Monocytes, % | 12.40 | NA |
Eosinophils, % | 2.40 | NA |
Basophils, % |
0.30 |
NA |
Clinical chemistry | ||
Creatinine, mg/dL | 2.8 | 1.1 |
Urea, mg/dL | 81 | 57 |
Bilirubin, mg/dL | 0.8 | 0.6 |
Total protein, g/dL | 6.8 | 7.8 |
Alanine aminotransferase, IU/L | 6 | 11 |
Aspartate aminotransferase, IU/L |
19 |
14 |
Electrolytes | ||
Sodium, mmol/L | 136 | NA |
Potassium, mmol/L | 5 | NA |
*NA, not available.
Page created: August 24, 2022
Page updated: September 21, 2022
Page reviewed: September 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.